loading...

Benuvia Agrees to Pay $3 MM and Issue Capital Stock Representing 8.0% of their previously announced SPAC merger with Pono Capital Corp JUPITER, FL / ACCESSWIRE / July 26, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced that it entered into a Forbearance and Settlement Agreement with Benuvia, Inc., formally Next Frontier Pharmaceuticals, a leading […]

This release has been corrected to include further details regarding the license agreement with Rejoy, Inc. JUPITER, FL / ACCESSWIRE / July 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it is developing a new product with a novel mechanism of action in the women’s sexual wellness category. It is covered by 2 issued […]

JUPITER, FL / ACCESSWIRE / July 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it is developing RJ-101 a new product with a novel mechanism of action in the women’s sexual wellness category. It is covered by 2 issued patents, US #10,357,452 and US #10,064,816, RJ-101 when applied to the nipple-areola area of the […]

Jupiter receives upfront payment plus double-digit royalties on revenues in 31 countries for clinically proven minoxidil (Rogaine®) products Minoxidil Booster and After Minoxidil Spray, and Photoci, a patented topical cream clinically proven to provide relief from psoriasis, vitiligo, and eczema JUPITER, FL / ACCESSWIRE / June 28, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced […]

Taisho to introduce a minoxidil booster developed by Applied Biology to boost minoxidil efficacy for Androgenetic Alopecia patients that do not respond to minoxidil The minoxidil sulfotransferase enzyme booster (SULT1A1) was acquired by Jupiter Wellness in an acquisition of assets that included issued patents, patent applications, products, clinical trial results, and licensing agreements from Applied […]

JUPITER, FL / ACCESSWIRE / June 22, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Prof. Andy Goren, MD, and John McCoy, PhD have joined Jupiter Wellness as Chief Medical Officer and Vice President of R&D respectively. Dr. Goren has over 20 years of experience in research, clinical development, and commercialization of breakthrough therapeutics […]

Assets include issued patents, patent applications, products, clinical trial results, licensing agreements Applied Biology generated approximately $8 million in revenues and $3 million in EBITDA in 2021 (unaudited) Regulatory expertise with US FDA, EMA, KFDA (Korea), PMDA (Japan), ANVISA (Brazil), CFDA (China) JUPITER, FL / ACCESSWIRE / June 21, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) […]

JUPITER, FL / ACCESSWIRE / June 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the purchase and retirement of 2,433,894 common shares, which reduces the Company’s outstanding common shares to 22,151,528, an approximate 10% reduction in shares outstanding. The Company previously announced a $5.0 million share buyback program. Under the program, shares of the […]

JUPITER, FL / ACCESSWIRE / June 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Paul Jones has joined Jupiter Wellness as Senior Project Manager. Paul joins Jupiter Wellness with over 20 years of experience building and directing operations, implementing improvements and overseeing projects in a wide range of industries. Most recently he was […]

JW-300 Demonstrated Efficacy in the Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo-Controlled Clinical Trial JUPITER, FL / ACCESSWIRE / May 4, 2022/Jupiter Wellness, Inc. (NASDAQ:JUPW) will present data for Jupiter’s JW-300, a cannabidiol topical treatment for first degree burns, at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference to take place […]

Subscribe today

Subscribe our Newsletter

Dolor sit Mollita harum ea ut eaque velit.

bg-image

Get in touch

Write us a message

Dolor sit Mollitia harum ea ut eaque velit

loader
Message Sent
Sorry, Message Not Sent. Try again later.